Journal
NATURE BIOTECHNOLOGY
Volume 31, Issue 3, Pages 233-239Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nbt.2508
Keywords
-
Categories
Funding
- Harvey L. Karp Discovery Award
- Bettencourt Schuller Foundation
- Medical Scientist Training Program
- US National Institutes of Health (NIH) [DP1MH100706]
- Keck Foundation
- McKnight Foundation
- Gates Foundation
- Damon Runyon Foundation
- Searle Scholars Foundation
- Klingenstein Foundation
- Simons Foundation
- Transformative R01
- Searle Scholars Program
- Rita Allen Scholars Program
- Irma T. Hirschl Award
- NIH [1DP2AI104556-01]
Ask authors/readers for more resources
Here we use the clustered, regularly interspaced, short palindromic repeats (CRISPR)-associated Cas9 endonuclease complexed with dual-RNAs to introduce precise mutations in the genomes of Streptococcus pneumoniae and Escherichia coli. The approach relies on dual-RNA:Cas9-directed cleavage at the targeted genomic site to kill unmutated cells and circumvents the need for selectable markers or counter-selection systems. We reprogram dual-RNA:Cas9 specificity by changing the sequence of short CRISPR RNA (crRNA) to make single- and multinucleotide changes carried on editing templates. Simultaneous use of two crRNAs enables multiplex mutagenesis. In S. pneumoniae, nearly 100% of cells that were recovered using our approach contained the desired mutation, and in E. coli, 65% that were recovered contained the mutation, when the approach was used in combination with recombineering. We exhaustively analyze dual-RNA:Cas9 target requirements to define the range of targetable sequences and show strategies for editing sites that do not meet these requirements, suggesting the versatility of this technique for bacterial genome engineering.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available